SCHEMBL6466441

SCHEMBL6466441

N#Cc1ccccc1CSC[C@H](N)C(=O)O

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
KIF11 P52732 7/20 0.44
KLKB1 P03952 1/20 0.44
ALDH1A1 P00352 2/20 0.41
DPP4 P27487 2/20 0.41
FAP Q12884 2/20 0.41
DPP8 Q6V1X1 2/20 0.41
DPP9 Q86TI2 2/20 0.41
NOS3 P29474 1/20 0.40
NOS1 P29475 1/20 0.40
NOS2 P35228 1/20 0.40
DPP7 Q9UHL4 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39
ALPI P09923 1/20 0.39
PKM P14618 1/20 0.39
PTGS1 P23219 1/20 0.39
XIAP P98170 1/20 0.39
SLC7A5 Q01650 1/20 0.39
DNMT1 P26358 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6466438 1.00 KIF11 (0.44) KIF11KLKB1ALDH1A1DPP4FAP
SCHEMBL42647 0.80 NOS3 (0.56) ALDH1A1DPP4FAPDPP8DPP9
SCHEMBL42646 0.80 NOS3 (0.56) ALDH1A1DPP4FAPDPP8DPP9
SCHEMBL2030783 0.80 NOS3 (0.56) ALDH1A1DPP4FAPDPP8DPP9
SCHEMBL29429685 0.80 NOS3 (0.56) ALDH1A1DPP4FAPDPP8DPP9
Hydrochloric Acid SCHEMBL25215525 0.79 NOS3 (0.55) ALDH1A1DPP4FAPDPP8DPP9
SCHEMBL11862665 0.78 KIF11 (0.51) KIF11KLKB1ALDH1A1
SCHEMBL10858055 0.78 KIF11 (0.51) KIF11KLKB1ALDH1A1SMN1; SMN2
SCHEMBL7300113 0.78 SMN1; SMN2 (0.50) KIF11KLKB1ALDH1A1SMN1; SMN2
SCHEMBL11862677 0.78 KIF11 (0.51) KIF11KLKB1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1516877-A1 Amine derivatives as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2005-03-23 EP disclosed
US-20030232864-A1 Novel Compounds and compositions as protease inhibitors AXYS PHARMACEUTICALS, INC. (US) 2003-12-18 US disclosed
US-6576630-B1 Alkanoyl substituted benzooxazoles or naphthooxazoles AXYS PHARMACEUTICALS, INC. 2003-06-10 US disclosed
EP-1161422-A1 AMINE DERIVATIVES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-12-12 EP disclosed
WO-2000055144-A1 AMINE DERIVATIVES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030232864-A1 Novel Compounds and compositions as protease inhibitors SERPINB1, CTRL, CTSZ KIF11 4593/4885KLKB1 535/4885ALDH1A1 3027/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.